$90.20
-0.40%Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
Capital-intensive operations require significant reinvestment. Monitor whether CapEx is maintenance or growth-oriented.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Neutral working capital impact. Changes in current assets and liabilities balanced out.
Solid cash generation: Positive free cash flow with reasonable earnings quality provides financial flexibility for growth investments, debt reduction, or shareholder returns.
TRNS โข NASDAQ
| Transcat, Inc. Cash Flow Statement | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 | Mar 2008 | Mar 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
5.4M | 14.5M | 13.6M | 10.7M | 11.4M | 7.8M | 8.1M | 7.1M | 5.9M | 4.5M | 4.1M | 4M | 4M | 3.7M | 3.3M | 2.8M | 1.5M | 1.6M | 2.4M | 2.1M | |
26.2M | 18.6M | 13.5M | 11M | 9.6M | 7.6M | 6.7M | 6.4M | 6M | 6.2M | 3.9M | 3.1M | 2.9M | 2.7M | 2.9M | 2.3M | 2.1M | 1.9M | 1.8M | 1.7M | |
827K | -5K | -1.6M | -186K | 559K | 176K | 575K | 741K | 765K | 63K | 136K | 779K | -310K | 43K | 91K | 138K | 35K | 246K | 40K | 1.1M | |
7.5M | 3.2M | 4.5M | 3.4M | 2.3M | 1.5M | 884K | 1.3M | 1.4M | 453K | 359K | 507K | 527K | 343K | 553K | 428K | 579K | 666K | 0.0 | 37K | |
-5.1M | -550K | 459K | 162K | 122K | 772K | 831K | 305K | 225K | 372K | 185K | 131K | -33K | 162K | 26K | 61K | 133K | 304K | 757K | -1.1M | |
(0.0) | (7.8M) | (3.1M) | (1.1M) | (3.9M) | (1.8M) | (1.4M) | (1.3M) | (2.1M) | (1.8M) | (1.3M) | (2.4M) | (2.2M) | (1.9M) | (1.7M) | (1.6M) | (741K) | (715K) | (0.0) | (0.0) | |
0.0 | 3.2M | 2.1M | -8M | -6.3M | 5.8M | -5.5M | -3.3M | -4.4M | -4.1M | 2.2M | -4.1M | 499K | -1.7M | -609K | -3.1M | 1.4M | -853K | -1.3M | -1.2M | |
34.9M | 39M | 32.6M | 17M | 17.6M | 23.6M | 11.6M | 12.6M | 9.9M | 7.5M | 11M | 4.4M | 7.6M | 5.2M | 6.3M | 2.6M | 5.6M | 3.8M | 3.6M | 2.6M | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-15.3M | -13.2M | -13.3M | -9.4M | -10.2M | -6.6M | -6.6M | -7M | -5.9M | -5.3M | -4.1M | -3.5M | -2M | -2.7M | -1.4M | -1.6M | -1.1M | -1.8M | -1.5M | -1.2M | |
-82.5M | -87.4M | -12.9M | -9.1M | -29.8M | -3.6M | -13.8M | -3.9M | (11K) | -7M | -13.9M | -7.3M | (0.0) | -7M | -3.1M | -3.4M | -1.9M | -5.6M | (0.0) | (0.0) | |
(0.0) | (0.0) | -15.5M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
0.0 | 16.6M | 0.0 | 10K | 109K | 17K | 170K | 16K | 11K | 59K | 31K | 51K | 249K | 0.0 | 0.0 | 0.0 | -1.1M | -6.8M | 0.0 | 0.0 | |
-97.8M | -84M | -41.7M | -18.5M | -39.9M | -10.2M | -20.2M | -10.9M | -5.9M | -12.2M | -18M | -10.7M | -1.7M | -9.7M | -4.5M | -5.1M | -4.1M | -7.4M | -1.5M | -1.2M | |
FINANCING ACTIVITIES | ||||||||||||||||||||
0.0 | -1.7M | 72.4M | 211K | -5.2M | -1.9M | -1.1M | 140K | -360K | 537K | 381K | 395K | -6.2M | 129K | 189K | -259K | -446K | 239K | 266K | 218K | |
0.0 | 28.6M | -45M | 665K | 28.9M | -10.8M | 9.3M | -1.8M | -4.5M | 8.2M | 6.9M | 4.6M | -424K | 4.7M | -1.9M | 2.7M | -1M | 3.2M | -2.6M | -1.4M | |
-469K | -3.6M | -4.9M | -447K | -6.7M | -3M | -2.8M | -145K | -360K | -98K | -73K | -71K | -6.5M | -110K | -247K | -559K | -647K | (0.0) | (0.0) | (0.0) | |
66.5M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 841K | -4M | -61K | 17K | 1K | -9K | -52K | -40K | 4K | 44K | 86K | 0.0 | |
66.5M | 26.9M | 27.4M | 876K | 23.7M | -12.7M | 8.2M | -1.7M | -4M | 4.8M | 7.2M | 5M | -6.6M | 4.8M | -1.8M | 2.4M | -1.5M | 3.5M | -2.2M | -1.2M | |
CASH FLOW SUMMARY | ||||||||||||||||||||
-103K | 24K | -228K | 821K | -625K | -772K | 145K | 262K | -288K | 57K | 328K | 1.3M | 305K | 47K | 5K | -12K | 23K | -21K | 9K | 1K | |
3.4M | -18.1M | 18.1M | 135K | 836K | 61K | -289K | 211K | -265K | 201K | 571K | 42K | -383K | 374K | 0.0 | -91K | 64K | -149K | -149K | 242K | |
1.5M | 19.6M | 1.5M | 1.4M | 560K | 499K | 788K | 577K | 842K | 641K | 65K | 23K | 406K | 32K | 32K | 123K | 59K | 208K | 357K | 115K | |
4.9M | 1.5M | 19.6M | 1.5M | 1.4M | 560K | 499K | 788K | 577K | 842K | 636K | 65K | 23K | 406K | 32K | 32K | 123K | 59K | 208K | 357K | |
19.6M | 25.8M | 19.3M | 7.5M | 7.5M | 17M | 5M | 5.6M | 4M | 2.3M | 6.9M | 939K | 5.7M | 2.6M | 4.9M | 926K | 4.5M | 2M | 2.1M | 1.5M |
TRNS - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-K 10-K 2026 FY FY | May 27, 2026 | March 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 26, 2026 | May 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 19, 2026 | May 13, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 09, 2026 | March 06, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 03, 2026 | February 03, 2026 | 2026 | |
10-Q 10-Q 2025 Q4 Q4 | February 03, 2026 | December 27, 2025 | 2025 | |
8-K 8-K 2026 N/A | January 08, 2026 | January 06, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 05, 2025 | September 27, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 03, 2025 | November 03, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 11, 2025 | September 10, 2025 | 2025 |
Continue your TRNS research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.